Håkon Bøås

1.1k total citations
24 papers, 247 citations indexed

About

Håkon Bøås is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Håkon Bøås has authored 24 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Håkon Bøås's work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (7 papers) and Respiratory viral infections research (6 papers). Håkon Bøås is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (7 papers) and Respiratory viral infections research (6 papers). Håkon Bøås collaborates with scholars based in Norway, Sweden and United States. Håkon Bøås's co-authors include German Tapia, Kjersti S. Rønningen, Lamprini Veneti, Eirik Alnes Buanes, Trond Rasmussen, Robert Whittaker, Olav Hungnes, Karoline Bragstad, Elina Seppälä and Margrethe Greve‐Isdahl and has published in prestigious journals such as PLoS ONE, PEDIATRICS and Stroke.

In The Last Decade

Håkon Bøås

23 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Håkon Bøås Norway 11 148 62 41 27 27 24 247
Ameema Asad Pakistan 6 135 0.9× 64 1.0× 22 0.5× 5 0.2× 44 1.6× 13 298
Ahmed Zaqout Qatar 7 146 1.0× 51 0.8× 7 0.2× 21 0.8× 19 0.7× 13 220
Sara F. Haddad Lebanon 11 70 0.5× 96 1.5× 26 0.6× 11 0.4× 20 0.7× 33 307
Min-Kyung Kim South Korea 8 175 1.2× 86 1.4× 17 0.4× 33 1.2× 19 0.7× 37 325
Danielle A. Rankin United States 9 86 0.6× 146 2.4× 32 0.8× 11 0.4× 32 1.2× 37 270
Yannick Vande Weygaerde Belgium 8 186 1.3× 75 1.2× 21 0.5× 11 0.4× 7 0.3× 23 296
Adnan Mushtaq United States 7 173 1.2× 86 1.4× 9 0.2× 9 0.3× 23 0.9× 7 282
Ioana Anca Romania 11 92 0.6× 194 3.1× 80 2.0× 27 1.0× 57 2.1× 31 346
Dithi Banerjee United States 10 253 1.7× 137 2.2× 15 0.4× 27 1.0× 24 0.9× 27 445

Countries citing papers authored by Håkon Bøås

Since Specialization
Citations

This map shows the geographic impact of Håkon Bøås's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Håkon Bøås with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Håkon Bøås more than expected).

Fields of papers citing papers by Håkon Bøås

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Håkon Bøås. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Håkon Bøås. The network helps show where Håkon Bøås may publish in the future.

Co-authorship network of co-authors of Håkon Bøås

This figure shows the co-authorship network connecting the top 25 collaborators of Håkon Bøås. A scholar is included among the top collaborators of Håkon Bøås based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Håkon Bøås. Håkon Bøås is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bøås, Håkon, et al.. (2025). Healthcare-associated COVID-19 infections and mortality. Journal of Hospital Infection. 158. 61–68. 2 indexed citations
3.
Bøås, Håkon, Ketil Størdal, Henrik Døllner, et al.. (2024). No association between disease severity and respiratory syncytial virus subtypes RSV-A and RSV-B in hospitalized young children in Norway. PLoS ONE. 19(3). e0298104–e0298104. 4 indexed citations
4.
Bøås, Håkon, Margrethe Larsdatter Storm, German Tapia, et al.. (2024). Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022. BMC Public Health. 24(1). 181–181. 5 indexed citations
5.
Ihle‐Hansen, Håkon, Håkon Bøås, German Tapia, et al.. (2023). Stroke After SARS-CoV-2 mRNA Vaccine: A Nationwide Registry Study. Stroke. 54(5). e190–e193. 11 indexed citations
6.
Veneti, Lamprini, Sara Viksmoen Watle, Jostein Starrfelt, et al.. (2023). Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022. International Journal of Infectious Diseases. 130. 182–188. 12 indexed citations
7.
Kristoffersen, Anja Bråthen, Håkon Bøås, Lamprini Veneti, et al.. (2022). Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway. Scandinavian Journal of Public Health. 50(6). 676–682. 12 indexed citations
8.
Whittaker, Robert, Margrethe Greve‐Isdahl, Håkon Bøås, et al.. (2022). COVID-19 Hospitalization Among Children <18 Years by Variant Wave in Norway. PEDIATRICS. 150(3). 24 indexed citations
9.
Ruiz, Paz Lopez‐Doriga, Nina Gunnes, Jon Michael Gran, et al.. (2022). Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway. Vaccine. 41(2). 323–332. 5 indexed citations
10.
Bøås, Håkon, Terese Bekkevold, Anne‐Marte Bakken Kran, et al.. (2022). Risk factors associated with severe disease in respiratory syncytial virus infected children under 5 years of age. Frontiers in Pediatrics. 10. 1004739–1004739. 16 indexed citations
11.
Bøås, Håkon, Terese Bekkevold, Anne‐Marte Bakken Kran, et al.. (2022). The burden of hospital-attended influenza in Norwegian children. Frontiers in Pediatrics. 10. 963274–963274. 2 indexed citations
12.
Seppälä, Elina, Anja Bråthen Kristoffersen, Håkon Bøås, et al.. (2022). Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998–2019. Vaccine. 40(23). 3142–3149. 7 indexed citations
13.
14.
Veneti, Lamprini, Elina Seppälä, Jostein Starrfelt, et al.. (2021). No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway. International Journal of Infectious Diseases. 115. 178–184. 22 indexed citations
15.
Bøås, Håkon, Terese Bekkevold, Anne‐Marte Bakken Kran, et al.. (2021). The burden of respiratory syncytial virus in children under 5 years of age in Norway. Journal of Infection. 84(2). 205–215. 11 indexed citations
16.
Veneti, Lamprini, Elina Seppälä, Margrethe Larsdatter Storm, et al.. (2021). Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021. PLoS ONE. 16(10). e0258513–e0258513. 29 indexed citations
17.
Lund‐Blix, Nicolai A., Kjersti S. Rønningen, Håkon Bøås, German Tapia, & Lene Frost Andersen. (2016). Plasma phospholipid pentadecanoic acid, EPA, and DHA, and the frequency of dairy and fish product intake in young children. Food & Nutrition Research. 60(1). 31933–31933. 11 indexed citations
18.
Tapia, German, Håkon Bøås, Eric J. de Muinck, et al.. (2015). Saffold Virus, a Human Cardiovirus, and Risk of Persistent Islet Autoantibodies in the Longitudinal Birth Cohort Study MIDIA. PLoS ONE. 10(8). e0136849–e0136849. 6 indexed citations
19.
Bøås, Håkon, German Tapia, Trond Rasmussen, & Kjersti S. Rønningen. (2013). Enterobius vermicularis and allergic conditions in Norwegian children. Epidemiology and Infection. 142(10). 2114–2120. 10 indexed citations
20.
Bøås, Håkon, et al.. (2012). Enterobius vermicularis and Risk Factors in Healthy Norwegian Children. The Pediatric Infectious Disease Journal. 31(9). 927–930. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026